Dr. Kim is the medical director of the Charles O’Brien Center for Addiction Treatment at the University of Pennsylvania Health System and provides services at Penn Medicine’s Perinatal Center of Excellence, also known as Mothers Matter, in collaboration with the Penn Presbyterian Medical Center and Maternity Care Coalition. He specializes in evaluating and treating substance use disorders, as well as co-occurring substance use and psychiatric disorders, including depression, anxiety, and ADHD. He also teaches medical students, residents and fellows on faculty at the University of Pennsylvania, as an assistant professor of clinical psychiatry. After a career in bioinformatics and genomic science at the Department of Energy’s Joint Genome Institute, he completed medical school at Saint George’s University, residency at the Creighton University School of Medicine, Phoenix Campus in Arizona, and fellowship in addiction psychiatry at the University of Pennsylvania.
Dr. Kim’s principle goal is to provide individuals with comprehensive, personalized care. He strives for meaningful and measurable results by incorporating a patient-driven decision making process. His clinical care is empathetic, non-judgmental, and respectful. He is dedicated to assisting individuals find their path into recovery, and to maintain sustainable results.
Dr. Cheatle earned his PhD in psychology at Princeton University. He completed his clinical internship at the University of Pennsylvania, School of Medicine and founded the Orthopaedic Pain Center at PENN. Currently he is Director of Behavioral Medicine at the PENN Pain Medicine Center and Director, Pain and Chemical Dependency Research at the Center for Studies of Addiction. He is an Associate Professor of Psychiatry at the Perelman School of Medicine, University of Pennsylvania. Dr. Cheatle specializes in the evaluation and treatment of chronic pain disorders from a biopsychosocial perspective and has been involved in extensive research including a NIH funded 5-year longitudinal study of the development of opioid use disorders in patients initiating prescription opioid therapy for chronic pain and as PI of a NIH/NIDA grant assessing phenotypic and genotypic markers of prescription opioid use disorder in patients with chronic pain. His main focus of research is pain management and substance use disorders in vulnerable populations (HIV/AIDS, psychiatric patients) and pain and suicidal ideation and behavior. Clinically, he specializes in assessing and treating patients with chronic pain and a co-occurring substance use disorder providing non-pharmacologic interventions to improve pain, function and mood and decreasing the potential of relapse.
Michele Gonen is a licensed clinical psychologist at the Charles O’Brien Center for Addiction Treatment and the Penn Outpatient Psychiatry Clinic. She completed her graduate studies at Hofstra University and her post-doctoral fellowship focused on Interprofessional Mental Health at the Edith Nourse Rogers Memorial VA Hospital. She enjoys providing individual, couples, and group therapy as well as supervision to psychology trainees and psychiatry residents. Dr. Gonen uses a variety of therapeutic approaches including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy, Motivational Interviewing, and Mindful Self-Compassion. Furthermore, she has training in specialized treatments for dual diagnosis (Seeking Safety), trauma (Prolonged Exposure, Cognitive Processing Therapy, Imagery Rehearsal Therapy for nightmares), insomnia (Cognitive Behavioral Therapy for Insomnia), obsessive compulsive disorder (Exposure and Response Prevention), stress and anxiety (Mindfulness Based Stress Reduction), and cancer-related fatigue (CBT-Hypnosis). She appreciates working collaboratively with providers and clients with a recovery-oriented, strengths-based approach.
Back to Top